An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
Titel:
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
Auteur:
Guttman-Yassky, Emma Simpson, Eric L Reich, Kristian Kabashima, Kenji Igawa, Ken Suzuki, Tetsuya Mano, Hirotaka Matsui, Takeshi Esfandiari, Ehsanollah Furue, Masutaka